Updates in the molecular epidemiology and systemic approaches to penile cancer

Jacob J. Adashek; Andrea Necchi; Philippe E. Spiess

doi:10.1016/j.urolonc.2019.04.012

Updates in the molecular epidemiology and systemic approaches to penile cancer

Jacob J. Adashek, Andrea Necchi, Philippe E. Spiess

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Review article › peer-review

Abstract

Penile cancer is a rare, but increasingly more common diagnosis. Although more there are more cases of penile cancer being diagnosed (the incidence is increasing), mortality (or conversely overall survival) has not changed. A detailed discussion of current treatments, along with potential therapeutic targets, and ongoing clinical trials is presented. This review gives insight to treatment strategies and novel modalities to combat a disease with sparse therapeutic options.

Original language	English
Pages (from-to)	403-408
Number of pages	6
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	37
Issue number	7
DOIs	https://doi.org/10.1016/j.urolonc.2019.04.012
Publication status	Published - Jul 2019

Keywords

Human papilloma virus
Novel therapy
Penile cancer

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.urolonc.2019.04.012

Fingerprint Dive into the research topics of 'Updates in the molecular epidemiology and systemic approaches to penile cancer'. Together they form a unique fingerprint.

Cite this

@article{78eeabee3aa040cd8d5d247bd7f6edeb,

title = "Updates in the molecular epidemiology and systemic approaches to penile cancer",

abstract = "Penile cancer is a rare, but increasingly more common diagnosis. Although more there are more cases of penile cancer being diagnosed (the incidence is increasing), mortality (or conversely overall survival) has not changed. A detailed discussion of current treatments, along with potential therapeutic targets, and ongoing clinical trials is presented. This review gives insight to treatment strategies and novel modalities to combat a disease with sparse therapeutic options.",

keywords = "Human papilloma virus, Novel therapy, Penile cancer",

author = "Adashek, {Jacob J.} and Andrea Necchi and Spiess, {Philippe E.}",

year = "2019",

month = jul,

doi = "10.1016/j.urolonc.2019.04.012",

language = "English",

volume = "37",

pages = "403--408",

journal = "Urologic Oncology",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Updates in the molecular epidemiology and systemic approaches to penile cancer

AU - Adashek, Jacob J.

AU - Necchi, Andrea

AU - Spiess, Philippe E.

PY - 2019/7

Y1 - 2019/7

N2 - Penile cancer is a rare, but increasingly more common diagnosis. Although more there are more cases of penile cancer being diagnosed (the incidence is increasing), mortality (or conversely overall survival) has not changed. A detailed discussion of current treatments, along with potential therapeutic targets, and ongoing clinical trials is presented. This review gives insight to treatment strategies and novel modalities to combat a disease with sparse therapeutic options.

AB - Penile cancer is a rare, but increasingly more common diagnosis. Although more there are more cases of penile cancer being diagnosed (the incidence is increasing), mortality (or conversely overall survival) has not changed. A detailed discussion of current treatments, along with potential therapeutic targets, and ongoing clinical trials is presented. This review gives insight to treatment strategies and novel modalities to combat a disease with sparse therapeutic options.

KW - Human papilloma virus

KW - Novel therapy

KW - Penile cancer

UR - http://www.scopus.com/inward/record.url?scp=85064941719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064941719&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2019.04.012

DO - 10.1016/j.urolonc.2019.04.012

M3 - Review article

C2 - 31053523

AN - SCOPUS:85064941719

VL - 37

SP - 403

EP - 408

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 7

ER -